General Information of Drug Transporter (DT)
DT ID DTD0257 Transporter Info
Gene Name SLC2A2
Transporter Name Glucose transporter type 2, liver
Gene ID
6514
UniProt ID
P11168

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 5 TF(s) Regulating This DT

        CEBPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in hepatoblastoma condition [1]

TF Protein Name

CCAAT/enhancer-binding protein alpha Transcription Factor Info

Studied Phenotype

Hepatoblastoma [ICD11: 2C12.01]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

Human hepatoblastoma cells (HepG2)

Detailed Description

CCAAT/enhancer-binding protein alpha (CEBPA) has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        CEBPB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in hepatoblastoma condition [1]

TF Protein Name

CCAAT/enhancer-binding protein beta Transcription Factor Info

Studied Phenotype

Hepatoblastoma [ICD11: 2C12.01]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

Human hepatoblastoma cells (HepG2)

Detailed Description

CCAAT/enhancer-binding protein beta (CEBPB) has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        FOSL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [2]

TF Protein Name

Fos-related antigen 2 Transcription Factor Info

Tissue

Brain; Breast; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Fos-related antigen 2 (FOSL2) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

        JUND 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [3]

TF Protein Name

Transcription factor JunD Transcription Factor Info

Tissue

Bone marrow; Brain; Colon; Coronary artery; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor JunD (JUND) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

        MAFB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in diabetes mellitus condition [4]

TF Protein Name

Transcription factor MafB Transcription Factor Info

Affected Drug/Substrate

Insulin

Studied Phenotype

Diabetes mellitus [ICD11: 5A10-5A14]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

C57BL/6J mice

Detailed Description

Transcription factor MafB (MAFB) has been reported to activate the transcription of SLC2A2 gene in diabetes mellitus condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

      Class 1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        SREBF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of GLUT2 gene in insulinoma condition [5]

TF Protein Name

Sterol regulatory element-binding protein 1 Transcription Factor Info

Studied Phenotype

Insulinoma [ICD11: 2C10.1]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

C57BL/129OlaHsd mice

Detailed Description

Sterol regulatory element-binding protein 1 (SREBF1) has been reported to activate the transcription of GLUT2 gene in insulinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        NR1H2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of GLUT2 gene in insulinoma condition [5]

TF Protein Name

Oxysterols receptor LXR-beta Transcription Factor Info

Studied Phenotype

Insulinoma [ICD11: 2C10.1]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

C57BL/129OlaHsd mice

Detailed Description

Oxysterols receptor LXR-beta (NR1H2) has been reported to activate the transcription of GLUT2 gene in insulinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        PPARA 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in hepatoblastoma condition [6]

TF Protein Name

Peroxisome proliferator-activated receptor alpha Transcription Factor Info

Affected Drug/Substrate

Insulin

Studied Phenotype

Hepatoblastoma [ICD11: 2C12.01]

Tissue

Liver

Related DT Changes

up regulating

Experimental Material

Human hepatoblastoma cells (HepG2)

Detailed Description

Peroxisome proliferator-activated receptor alpha (PPARA), influenced by the exogenous oleic Acid, has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition , which leads to an increased expression of the drug transporter Glucose transporter type 2.

       Transcriptional Phenomenon 2

Activation of SLC2A2 gene in type 2 diabetes condition [7]

TF Protein Name

Peroxisome proliferator-activated receptor alpha Transcription Factor Info

Studied Phenotype

Type 2 diabetes [ICD11: 5A11]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

Zucker diabetic fatty rat

Detailed Description

Peroxisome proliferator-activated receptor alpha (PPARA) has been reported to activate the transcription of SLC2A2 gene in type 2 diabetes condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

      Class 2.2: Other C4 zinc finger-type factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        GATA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [8]

TF Protein Name

Erythroid transcription factor Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Erythroid transcription factor (GATA1) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

        GATA3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [9]

TF Protein Name

Trans-acting T-cell-specific transcription factor GATA-3 Transcription Factor Info

Tissue

Blood; Brain; Breast; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

      Class 2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [2]

TF Protein Name

Myc-associated zinc finger protein Transcription Factor Info

Tissue

Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 7 TF(s) Regulating This DT

        CDX2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in health condition [10]

TF Protein Name

Homeobox protein CDX-2 Transcription Factor Info

Studied Phenotype

Heallth [ICD11: N.A]

Related DT Changes

Up regulating

Detailed Description

Homeobox protein CDX-2 (CDX2), influenced by the faecalibacterium prausnitzii, has been reported to activate the transcription of SLC2A2 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        DUX4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [9]

TF Protein Name

Double homeobox protein 4 Transcription Factor Info

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Double homeobox protein 4 (DUX4) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

        HNF1A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in type 2 diabetes condition [11]

TF Protein Name

Hepatocyte nuclear factor 1-alpha Transcription Factor Info

Studied Phenotype

Type 2 diabetes [ICD11: 5A11]

Tissue

Embryo

Related DT Changes

Up regulating

Experimental Material

Mouse embryo fibroblast cells (NIH-3T3)

Detailed Description

Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of SLC2A2 gene in type 2 diabetes condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        HNF1B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in renal cysts condition [12]

TF Protein Name

Hepatocyte nuclear factor 1-beta Transcription Factor Info

Studied Phenotype

Renal cysts [ICD11: GB80]

Tissue

Kidney

Related DT Changes

Up regulating

Experimental Material

Zebrafish TgPT::EGFP)

Detailed Description

Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to activate the transcription of SLC2A2 gene in renal cysts condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        NKX6-1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in diabetes mellitus condition [13]

TF Protein Name

Homeobox protein Nkx-6.1 Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Diabetes mellitus [ICD11: 5A10-5A14]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

129Sv-C57BL6/J hybrid mice

Detailed Description

Homeobox protein Nkx-6.1 (NKX6-1) has been reported to activate the transcription of SLC2A2 gene in diabetes mellitus condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        ONECUT1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in hepatoblastoma condition [14]

TF Protein Name

Hepatocyte nuclear factor 6 Transcription Factor Info

Studied Phenotype

Hepatoblastoma [ICD11: 2C12.01]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

Human hepatoblastoma cells (HepG2)

Detailed Description

Hepatocyte nuclear factor 6 (ONECUT1) has been reported to activate the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

        PBX3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [2]

TF Protein Name

Pre-B-cell leukemia transcription factor 3 Transcription Factor Info

Tissue

Blood; Brain

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

      Class 3.2: Paired box factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        PAX6 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Repression of SLC2A2 gene in diabetes mellitus condition [15]

TF Protein Name

Paired box protein Pax-6 Transcription Factor Info

Affected Drug/Substrate

Insulin

Studied Phenotype

Diabetes mellitus [ICD11: 5A10-5A14]

Tissue

Pancreas

Related DT Changes

Down regulating

Experimental Material

Pax6 KO mice

Detailed Description

Paired box protein Pax-6 (PAX6) has been reported to repress the transcription of SLC2A2 gene in diabetes mellitus condition, which leads to a decreased expression of the drug transporter Glucose transporter type 2.

      Class 3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        FOXA2 

Click to Show/Hide to Show 3 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in type 2 diabetes condition [11]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Studied Phenotype

Type 2 diabetes [ICD11: 5A11]

Tissue

Embryo

Related DT Changes

Up regulating

Experimental Material

Mouse embryo fibroblast cells (NIH-3T3)

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to activate the transcription of SLC2A2 gene in type 2 diabetes condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

       Transcriptional Phenomenon 2

Repression of SLC2A2 gene in insulinoma condition [16]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Insulinoma [ICD11: 2C10.1]

Tissue

Pancreas

Related DT Changes

Down regulating

Experimental Material

Rat insulinoma cells (INS-1)

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to repress the transcription of SLC2A2 gene in insulinoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 2.

       Transcriptional Phenomenon 3

Repression of SLC2A2 gene in hepatoblastoma condition [14]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Studied Phenotype

Hepatoblastoma [ICD11: 2C12.01]

Tissue

Liver

Related DT Changes

Down regulating

Experimental Material

Human hepatoblastoma cells (HepG2)

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to repress the transcription of SLC2A2 gene in hepatoblastoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 2.

        FOXA3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in effects of [17]

TF Protein Name

Hepatocyte nuclear factor 3-gamma Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Effects of hunger [ICD11: NF07.0]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

C57BL/6 mice

Detailed Description

Hepatocyte nuclear factor 3-gamma (FOXA3) has been reported to activate the transcription of SLC2A2 gene in effects of hunger condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

      Class 3.7: ARID domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        ARID3A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [8]

TF Protein Name

AT-rich interactive domain-containing protein 3A Transcription Factor Info

Tissue

Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.

TF Superclass 6: Immunoglobulin fold

      Class 6.2: STAT domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        STAT3 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A2 gene in obesity condition [18]

TF Protein Name

Signal transducer and activator of transcription 3 Transcription Factor Info

Affected Drug/Substrate

2-deoxyglucose

Studied Phenotype

Obesity [ICD11: 5B81]

Tissue

Pancreas

Related DT Changes

Up regulating

Experimental Material

RIP-Cre-STAT3/loxP hybrid mice

Detailed Description

Signal transducer and activator of transcription 3 (STAT3) has been reported to activate the transcription of SLC2A2 gene in obesity condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

       Transcriptional Phenomenon 2

Activation of SLC2A2 gene in health condition [19]

TF Protein Name

Signal transducer and activator of transcription 3 Transcription Factor Info

Affected Drug/Substrate

2-deoxyglucose

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Liver

Related DT Changes

Up regulating

Experimental Material

White Leghorn chicken hepatocyte isolates

Detailed Description

Signal transducer and activator of transcription 3 (STAT3) has been reported to activate the transcription of SLC2A2 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 2.

      Class 6.7: Grainyhead domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GRHL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A2 gene [3]

TF Protein Name

Grainyhead-like protein 2 homolog Transcription Factor Info

Tissue

Breast; Bronchus; Ovary

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC2A2 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 2.
References
1 CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells. Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):83-90.
2 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-360. (ID:ENSG00000163581)
3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
4 MafB Maintains beta-Cell Identity under MafA-Deficient Conditions. Mol Cell Biol. 2022 Aug 18;42(8):e0054121.
5 Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology. 2006 Aug;147(8):3898-905.
6 Conjugated linoleic acid isomers and their precursor fatty acids regulate peroxisome proliferator-activated receptor subtypes and major peroxisome proliferator responsive element-bearing target genes in HepG2 cell model. J Zhejiang Univ Sci B. 2013 Feb;14(2):115-23.
7 Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11921-6.
8 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
9 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
10 Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011;6(9):e24585.
11 Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1alpha and 3beta. J Biol Chem. 2000 Jun 16;275(24):18358-65.
12 Transcriptional profiling of the zebrafish proximal tubule. Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F478-F488.
13 Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep. 2013 Sep 26;4(6):1262-75.
14 Association between hepatocyte nuclear factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity but inhibits HNF-6 DNA binding. Mol Cell Biol. 2003 Jan;23(2):437-49.
15 The transcription factor Pax6 is required for pancreatic beta cell identity, glucose-regulated ATP synthesis, and Ca2+ dynamics in adult mice. J Biol Chem. 2017 May 26;292(21):8892-8906.
16 Foxa2 (HNF3beta ) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J Biol Chem. 2002 May 17;277(20):17564-70.
17 Foxa3 (hepatocyte nuclear factor 3gamma ) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast. J Biol Chem. 2001 Nov 16;276(46):42812-7.
18 Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. Biochem Biophys Res Commun. 2004 Jul 9;319(4):1159-70.
19 Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes. J Cell Physiol. 2009 Mar;218(3):643-52.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.